رادار التجارب السريرية

رادار التجارب AI مرشح للتجارب أو مريض مقدم رعاية المريض محترف الرعاية الصحية محترف التكنولوجيا الحيوية مستثمر في التكنولوجيا الحيوية باحث أخرى
	دعونا نناقش ونستكشف التجارب السريرية مع AstraZeneca بصفتها الراعي الرئيسي أو الشريك. يتم الآن عرض التجارب السريرية الخاصة بـ السكري. يمكنني مساعدتك على فهم الحالات الصحية والعلاجات والعثور على التجارب السريرية القريبة.

عنوان الدراسة	الحالة
Renal Mechanism of Action/Splay vs. TmG (MOA) NCT00726505	متوقف نهائيًا
Chinese Multiple Dose Escalation (MDE) High Dose Study (COTA China PK) NCT05437848	مكتمل
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus NCT02229383	مكتملالنتائج المنشورة
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus NCT00108004	مكتمل
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin NCT00701935	متوقف نهائيًاالنتائج المنشورة
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes NCT00064714	مكتمل
Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus NCT01095991	مكتمل
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus NCT01082120	مكتمل
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo NCT02229396	مكتملالنتائج المنشورة
A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus (IRAK4) NCT07433062	يقبل مشاركين
Impact of Diabetes on Left Ventricular Remodeling (P3) NCT01052272	مكتملالنتائج المنشورة
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE) NCT06579105	مكتمل
Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus NCT02500979	مكتملالنتائج المنشورة
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone NCT02419612	مكتملالنتائج المنشورة
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old NCT03199053	مكتملالنتائج المنشورة
Evaluation of the Effect of Pramlintide on Satiety and Food Intake NCT00042601	مكتمل
To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients NCT04445714	مكتملالنتائج المنشورة
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas NCT00313313	مكتملالنتائج المنشورة
Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients NCT01152385	مكتملالنتائج المنشورة
Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00316082	مكتملالنتائج المنشورة
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes NCT00229658	مكتملالنتائج المنشورة
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients NCT00972244	مكتملالنتائج المنشورة
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00327015	مكتملالنتائج المنشورة
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients NCT01020123	مكتملالنتائج المنشورة
Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study (FORTUNA) NCT01140542	مكتمل
Phase III Insulin Add-On Asia Regional Program - ST NCT02096705	مكتملالنتائج المنشورة
A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus NCT00313183	مكتمل
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus (DERISC) NCT02426541	مكتملالنتائج المنشورة
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus NCT01206647	غير معروف
A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM) NCT02367066	مكتملالنتائج المنشورة
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease (PLANET 1) NCT00296374	مكتملالنتائج المنشورة
Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients NCT00658463	مكتمل
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) NCT06099067	مكتمل
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM) NCT01165268	مكتمل
Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes NCT03377335	غير معروف
Bioequivalence Study NCT01874080	مكتمل
GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes NCT00229710	متوقف نهائيًا
Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes NCT04556760	مكتملالنتائج المنشورة
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (THEMIS) NCT01991795	مكتملالنتائج المنشورة
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients NCT01055652	مكتمل
GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus NCT00226330	متوقف نهائيًا
Evaluation of the Bioavailability of Pramlintide NCT00042471	مكتمل
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus NCT00135330	مكتملالنتائج المنشورة
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus NCT01876849	مكتمل
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin (GENERATION) NCT01006603	مكتملالنتائج المنشورة
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1) NCT02268214	مكتملالنتائج المنشورة
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2) NCT02460978	مكتملالنتائج المنشورة
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus NCT00107107	مكتمل
Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes (PROMPT) NCT01006590	مكتملالنتائج المنشورة
Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice (FLORA) NCT02719132	مسحوب

المرحلة

النوع

نوع الدراسة

الفئة العمرية

الجنس

دواء وهمي

المرحلة

النوع

نوع الدراسة

الفئة العمرية

الجنس